Elenbecestat
- Generic Name
- Elenbecestat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18F3N5O2S
- CAS Number
- 1388651-30-6
- Unique Ingredient Identifier
- RXJ96XL94H
- Background
Elenbecestat is under investigation in clinical trial NCT02956486 (A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease).
- Associated Conditions
- -
- Associated Therapies
- -
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
- First Posted Date
- 2016-11-06
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 2212
- Registration Number
- NCT02956486
- Locations
- 🇯🇵
Eisai Trial Site 1, Osaka, Japan
🇬🇧Facility #1, London, United Kingdom
🇺🇸Facility #11, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath